NO985896L - Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloks - Google Patents

Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloks

Info

Publication number
NO985896L
NO985896L NO985896A NO985896A NO985896L NO 985896 L NO985896 L NO 985896L NO 985896 A NO985896 A NO 985896A NO 985896 A NO985896 A NO 985896A NO 985896 L NO985896 L NO 985896L
Authority
NO
Norway
Prior art keywords
desetylox
oxybutynin
treatment
urinary incontinence
incontinence
Prior art date
Application number
NO985896A
Other languages
English (en)
Other versions
NO985896D0 (no
Inventor
Gunnar Aberg
John R Mccullough
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO985896L publication Critical patent/NO985896L/no
Publication of NO985896D0 publication Critical patent/NO985896D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO985896A 1996-06-28 1998-12-16 Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloksybutynin NO985896D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/671,976 US5736577A (en) 1995-01-31 1996-06-28 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
PCT/US1997/011570 WO1998000126A1 (en) 1996-06-28 1997-06-27 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin

Publications (2)

Publication Number Publication Date
NO985896L true NO985896L (no) 1998-12-16
NO985896D0 NO985896D0 (no) 1998-12-16

Family

ID=24696647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985896A NO985896D0 (no) 1996-06-28 1998-12-16 Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloksybutynin

Country Status (14)

Country Link
US (1) US5736577A (no)
EP (1) EP0914113A1 (no)
JP (1) JP2000513724A (no)
AU (1) AU732568B2 (no)
BR (1) BR9710031A (no)
CA (1) CA2257121C (no)
CZ (1) CZ428398A3 (no)
NO (1) NO985896D0 (no)
NZ (1) NZ333282A (no)
PL (1) PL190483B1 (no)
RU (1) RU2195276C2 (no)
SK (1) SK178698A3 (no)
UA (1) UA61916C2 (no)
WO (1) WO1998000126A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123961A (en) * 1996-09-25 2000-09-26 Bridge Pharma, Inc. Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin
US6130242A (en) * 1997-12-31 2000-10-10 Sepracor Inc. S-procyclidine for treating urinary incontinence
US20010038855A1 (en) * 1998-06-05 2001-11-08 Desjardin Michael A. Dosage form for administering prescribed dose
AU767877B2 (en) * 1999-05-20 2003-11-27 Sepracor, Inc. Methods for treatment of asthma using S-oxybutynin
WO2000076490A2 (en) * 1999-06-10 2000-12-21 Sepracor Inc. Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin
US6248359B1 (en) 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
MX342305B (es) * 2000-04-26 2016-09-23 Watson Pharmaceuticals Inc * Minimizacion de experiencias adversas asociadas con la terapia con oxibutinina.
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ES2283665T3 (es) * 2000-08-03 2007-11-01 Antares Pharma Ipl Ag Composicion para administracion transdermica y/o transmucosa de compuestos activos que asegura unos niveles terapeuticamente adecuados.
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
WO2005039531A1 (en) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US6545046B2 (en) * 2000-08-30 2003-04-08 Theramax Inc. Method for enhanced delivery of oxybutynin and compositions thereof
DE10103262A1 (de) * 2001-01-25 2002-08-01 Axel Schmidt-Dossi Arzneimittel gegen Blasenfunktionsstörung
CN1536986B (zh) * 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的***内药物递送装置
US20020169208A1 (en) * 2001-04-03 2002-11-14 Pascal Druzgala Novel anticholinergic compounds and methods of use
US20030027856A1 (en) * 2001-06-29 2003-02-06 Aberg A.K. Gunnar Tolterodine metabolites
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
TW200300079A (en) * 2001-11-05 2003-05-16 Upjohn Co Antimuscarinic aerosol
US7921999B1 (en) * 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
EP1386604A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
CA2646667C (en) * 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
BRPI0812000A2 (pt) * 2007-05-30 2014-11-18 Microdose Therapeutx Inc Métodos e composições para administração de oxibutinina
JP5782635B2 (ja) * 2011-01-12 2015-09-24 有限会社センチュリーテック 搬送装置
DE102020117734A1 (de) * 2020-05-15 2021-11-18 Farco-Pharma Gmbh Oxybutynin für die intravesikale Anwendung
EP3909570A1 (de) * 2020-05-15 2021-11-17 Farco-Pharma GmbH Oxybutynin für die intravesikale anwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124473C (no) * 1960-07-26
JPH0755904B2 (ja) * 1986-05-14 1995-06-14 小玉株式会社 膀胱疾患治療剤
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol
KR960704579A (ko) * 1993-09-29 1996-10-09 에드워드 엘. 만델 옥시부티닌용 모노글리세리드/락테이트 에스테르 투과 촉진제(Monoglyceride/lactate Ester Permeation Enhancer for Oxybutynin)
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin

Also Published As

Publication number Publication date
RU2195276C2 (ru) 2002-12-27
AU3513797A (en) 1998-01-21
EP0914113A1 (en) 1999-05-12
WO1998000126A1 (en) 1998-01-08
US5736577A (en) 1998-04-07
BR9710031A (pt) 1999-08-10
CZ428398A3 (cs) 1999-06-16
PL190483B1 (pl) 2005-12-30
CA2257121A1 (en) 1998-01-08
NZ333282A (en) 2000-06-23
PL330752A1 (en) 1999-05-24
UA61916C2 (en) 2003-12-15
JP2000513724A (ja) 2000-10-17
NO985896D0 (no) 1998-12-16
CA2257121C (en) 2006-10-24
AU732568B2 (en) 2001-04-26
SK178698A3 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
NO985896L (no) Behandling av urininkontinens ved bruk av (S)-oksybutynin og (S)-desetyloks
AU7608396A (en) Devices and methods for assessment and treatment of urinary and fecal incontinence
EE9700267A (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
GB9425578D0 (en) redial treatment of urinary incontinence
PL334398A1 (en) Disposable elastic thermal dorsum bandage and method of treating backache
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
IL138871A0 (en) Flushable diaper and method
AU5729098A (en) Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
EP0954303A4 (en) METHODS FOR TREATING MENTAL ILLNESSES, INFLAMMATION AND PAIN
ZA978427B (en) Method of treating urinary incontinence
AU9016898A (en) Methods and compositions for treatment of restenosis
NO990914D0 (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
AU3785497A (en) Drug for the prevention or treatment of pollakiuria and urinary incontinence
ZA971607B (en) Methods of treatment of allergic diseases
NO985974D0 (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
AU1196601A (en) Methods of diagnosing and treating urinary incontinence
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
AU2845897A (en) Photosensitive elements and their process of use
AU8809098A (en) Procedure and apparatus for the treatment of waste
GB9626634D0 (en) Wastewater treatment plant and method of use therein
AU6388396A (en) Electromagnetic therapeutic treatment device and methods of using same
EP0909170A4 (en) METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE USING ENANTIOMERIC ENRICHED (S) -TRIDIHEXETHYL
IL141264A0 (en) Treatment of fecal incontinence
CZ362797A3 (cs) Způsob zpracování pojiv a jejich použití
ZA98531B (en) Treatment of urinary incontinece